Stock M3V MEVIS MEDICAL SOLUTIONS AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials MeVis Medical Solutions AG

Equities

M3V

DE000A0LBFE4

Advanced Medical Equipment & Technology

Market Closed - Xetra
Other stock markets
 11:36:03 2024-04-26 am EDT 		5-day change 1st Jan Change
25.8 EUR +0.78% Intraday chart for MeVis Medical Solutions AG +1.57% +2.38%
Feb. 20 MeVis Medical Solutions AG Reports Earnings Results for the Full Year Ended September 30, 2023 CI
2023 MeVis Medical Solutions AG Reports Earnings Results for the Half Year Ended March 31, 2023 CI

Valuation

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Capitalization 1 62.61 54.24 57.88 59.33 62.24 51.69
Enterprise Value (EV) 1 59.13 51.63 53.92 51.71 52.92 43.94
P/E ratio 8.73 x 6.72 x 10.1 x 13.1 x 7.99 x 10.5 x
Yield - - - - - 3.35%
Capitalization / Revenue 3.74 x 3 x 3.38 x 3.66 x 3.32 x 2.98 x
EV / Revenue 3.53 x 2.86 x 3.15 x 3.19 x 2.82 x 2.53 x
EV / EBITDA 7.97 x 6.99 x 8.94 x 13.2 x 8.07 x 8.86 x
EV / FCF -11.3 x 15.1 x 59.1 x 6.22 x 19.3 x 10.3 x
FCF Yield -8.88% 6.63% 1.69% 16.1% 5.19% 9.73%
Price to Book 1.95 x 3.04 x 3.25 x 3.33 x 3.49 x 2.9 x
Nbr of stocks (in thousands) 1,820 1,820 1,820 1,820 1,820 1,820
Reference price 2 34.40 29.80 31.80 32.60 34.20 28.40
Announcement Date 1/30/19 1/29/20 1/28/21 1/27/22 1/26/23 2/20/24
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net sales 1 16.76 18.07 17.13 16.21 18.76 17.34
EBITDA 1 7.422 7.39 6.03 3.929 6.559 4.96
EBIT 1 6.869 7.134 5.863 3.803 6.466 4.864
Operating Margin 40.99% 39.47% 34.22% 23.46% 34.46% 28.05%
Earnings before Tax (EBT) 1 7.257 8.156 5.794 4.631 7.876 5.034
Net income 1 7.171 8.071 5.704 4.546 7.789 4.92
Net margin 42.79% 44.66% 33.3% 28.04% 41.52% 28.37%
EPS 2 3.940 4.435 3.134 2.498 4.280 2.703
Free Cash Flow 1 -5.25 3.423 0.9124 8.312 2.748 4.277
FCF margin -31.33% 18.94% 5.33% 51.27% 14.65% 24.66%
FCF Conversion (EBITDA) - 46.33% 15.13% 211.58% 41.9% 86.24%
FCF Conversion (Net income) - 42.42% 16% 182.86% 35.28% 86.95%
Dividend per Share - - - - - 0.9500
Announcement Date 1/30/19 1/29/20 1/28/21 1/27/22 1/26/23 2/20/24
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 3.48 2.6 3.95 7.62 9.32 7.74
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -5.25 3.42 0.91 8.31 2.75 4.28
ROE (net income / shareholders' equity) 22.2% 45.3% 32% 25.5% 43.7% 27.6%
ROA (Net income/ Total Assets) 9.81% 18.6% 14.2% 8.59% 13.8% 10.3%
Assets 1 73.08 43.38 40.25 52.9 56.6 47.95
Book Value Per Share 2 17.60 9.790 9.790 9.790 9.790 9.790
Cash Flow per Share 2 1.910 1.430 2.170 4.190 5.120 4.250
Capex 1 0.1 0.2 0.1 0.05 0.13 0.08
Capex / Sales 0.61% 1.12% 0.6% 0.31% 0.71% 0.46%
Announcement Date 1/30/19 1/29/20 1/28/21 1/27/22 1/26/23 2/20/24
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Software & Technology Services

1st Jan change Capi.
MEVIS MEDICAL SOLUTIONS AG Stock MeVis Medical Solutions AG
+2.38% 50.13M
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
+4.36% 32.47B
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+14.14% 7.45B
SECTRA AB Stock Sectra AB
+22.93% 3.89B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-16.29% 3.17B
OMNICELL, INC. Stock Omnicell, Inc.
-25.96% 1.28B
LUNIT INC. Stock Lunit Inc.
-36.14% 1.09B
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-35.42% 902M
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
-0.13% 893M
VERADIGM INC. Stock Veradigm Inc.
-24.12% 857M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. M3V Stock
  4. Financials MeVis Medical Solutions AG